Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Small caps round-up: Gresham Computing, Alliance Pharma, Young and Co's...

Tue, 10th Jul 2012 08:55
Gresham Computing has unveiled Australia and New Zealand Banking Group as its partner in a previously announced significant contract win. Under the deal Gresham will for a third time partner the bank, providing cash and information management solutions for corporate clients in an effort to increase visibility, control and efficiency in these areas. The bank said it believes the deal is the start of a long-term partnership for the two companies. Alliance Pharma, a speciality pharmaceutical company, has said trading during the six months ended June 30th has been in line with management's expectations, with turnover of around ÂŁ22m. The Hydromol produce continues to perform well, with growth of 28% over the first half of 2011. The firm said it is continuing to explore a number of acquisition opportunities, some of which are at a very advanced stage. The temporary suspension of the ImmuCyst product is expected to end in late 2013. Young & Co's Brewery has said recent trading has improved significantly since the poor performance in the first seven weeks, as reported earlier in the year. Consequently managed house revenue for the first thirteen weeks was up 10.1%, and up 4.0% on a like-for-like basis. Managed house trading has benefited from a number of factors including the impact of last year's investments in new pubs, the addition of three sites transferred from tenancy, and strong trading during the Diamond Jubilee celebrations. The firm is anticipating a strong period of trading during the Olympics and it remains confident in its strategy, believing well-invested estate and management focus on growth should continue to drive superior like-for-like performance. Leni Oil & Gas has completed the first five planned workovers on the Goudron Field and has confirmed that an average production potential per well of 10 barrels of oil per day (bopd) is achievable from existing wells. The programme was completed in 35 days at a cost of around $50,000. The upcoming transfer of the incremental production services contract to Goudron E&P will trigger payment of outstanding considerations to Cameron Oil and Gas and Sorgenia International, which the company is intending to finance out of the proceeds of the sale of the Spanish assets. The transfer is intended to expand the workover programme and to commence detailed planning for new infill wells. Sphere Medical, a diagnostic product developer, has received an order for cardiopulmonary bypass monitors and microanalyser consumables for delivery in the fourth quarter of 2012 from Sorin Group. The order represents the first sale for the development and supply agreement relating to the CPB product which will be used by Sorin Group in market assessment studies which are scheduled to commence later this year. Sphere described the sale as an "important milestone" which demonstrates its ability to partner its products with global medical device companies. NR

Related News

LONDON BROKER RATINGS: Barclays ups British Land; BofA cuts Vodafone
26 May 2026

LONDON BROKER RATINGS: Barclays ups British Land; BofA cuts Vodafone

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and Friday:

Sales, profits fizz at Young & Co's
21 May 2026

Sales, profits fizz at Young & Co's

(Sharecast News) - Young & Co's Brewery toasted record earnings on Thursday as the 195-year-old firm posted its first set of results since transferrin...

Alliance Pharma News

Alliance Pharma loss narrows in 2024 due to reduced impairment charges
8 Apr 2025

Alliance Pharma loss narrows in 2024 due to reduced impairment charges

(Alliance News) - Alliance Pharma PLC on Tuesday reported a narrowed loss for 2024 despite a decline in revenue, due to a reduction in impairment char...

Alliance Pharma confident despite softer sales
8 Apr 2025

Alliance Pharma confident despite softer sales

(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.

Alliance Pharma board backs final GBP362 million takeover bid
10 Mar 2025

Alliance Pharma board backs final GBP362 million takeover bid

(Alliance News) - Alliance Pharma PLC on Monday said it has agreed to a final increased cash offer of 64.75 pence per share from Dbay Advisors Ltd and...

Alliance Pharma agrees to take-private deal
10 Mar 2025

Alliance Pharma agrees to take-private deal

(Sharecast News) - Speciality drugmaker Alliance Pharma has agreed to be taken private in a deal valued at more than £360.0m.

Alliance Pharma expects to post flat annual profit, revenue decline
31 Jan 2025

Alliance Pharma expects to post flat annual profit, revenue decline

(Alliance News) - Alliance Pharma PLC on Friday said it expects to report 2024 profit broadly in line with the year before, despite a decline in annua...

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next
31 Jan 2025

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: